CAR T-cell therapy is a type of immunotherapy that displays remarkable potential to treat B-cell cancers. In this treatment, a protein on the surface of B-cells called CD19 is targeted, allowing for the specific killing of B-cells in patients. However, CD19 is a “difficult to express” protein, characterized by high levels of aggregated protein and […]
Read More